Tonix Pharmaceuticals Unveils TONIX ONE™, a Game-Changing Digital Migraine Platform

Tonix Pharmaceuticals (Nasdaq: TNXP) has introduced TONIX ONE™, an innovative digital platform designed to empower migraine patients by simplifying their treatment journey. Through strategic partnerships with UpScript Telemedicine, ProModRx, Blink Health, and a leading symptom-tracking mobile app, the platform offers seamless access to education, telehealth consultations, e-prescriptions, and medication fulfillment—all in one place. Patients can now move from tracking their symptoms to obtaining treatment within hours, eliminating barriers that often delay migraine care.

“Our goal with TONIX ONE is to create a patient-first solution that connects individuals to real-time telehealth support, digital prescription services, and treatment education with ease,” said Scott Szymanski, VP of Sales and Marketing, Migraine at Tonix. CEO Seth Lederman, M.D., emphasized that the platform strengthens Tonix’s commitment to innovation and accessibility, ensuring that patients receive effective, timely treatment. By leveraging cutting-edge digital health tools, TONIX ONE aims to revolutionize migraine management and enhance patient outcomes.